Skip to main content
David Wyles, MD, Infectious Disease, Denver, CO

DavidLWylesMD

Infectious Disease Denver, CO

Professor of Medicine, University of Colorado School of Medicine. Chief, Division of Infectious Diseases, Denver Health Medical Center

Dr. Wyles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Wyles' full profile

Already have an account?

  • Office

    777 Bannock St
    Denver, CO 80204
    Phone+1 303-602-5148

Education & Training

  • University of Colorado
    University of ColoradoFellowship, Infectious Disease, 2001 - 2004
  • University of Colorado
    University of ColoradoResidency, Internal Medicine, 1998 - 2001
  • Northwestern University The Feinberg School of Medicine
    Northwestern University The Feinberg School of MedicineClass of 1998

Certifications & Licensure

  • CA State Medical License
    CA State Medical License 2005 - Present
  • CO State Medical License
    CO State Medical License 2000 - 2025
  • American Board of Internal Medicine Infectious Disease

Awards, Honors, & Recognition

  • CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2011-2012

Clinical Trials

Publications & Presentations

PubMed

Press Mentions

  • The CDC Says Fully Vaccinated People Don’t Need Masks Anymore. Here’s What That Means in Colorado
    The CDC Says Fully Vaccinated People Don’t Need Masks Anymore. Here’s What That Means in ColoradoMay 14th, 2021
  • From Starvation to Overdose, Coronavirus’ Hidden Toll Emerges in Colorado’s Death Data
    From Starvation to Overdose, Coronavirus’ Hidden Toll Emerges in Colorado’s Death DataFebruary 17th, 2021
  • New DAA for Hepatitis C Effective in Large Majority of Patients with Resistance-Associated Substitutions
    New DAA for Hepatitis C Effective in Large Majority of Patients with Resistance-Associated SubstitutionsAugust 28th, 2018
  • Join now to see all

Grant Support

  • Analysis Of HIV/HCV Sexual Transmission Pairs Using Ultra-Deep SequencingNational Institute Of Allergy And Infectious Diseases2012
  • An In Vitro System To Study Antiviral Strategies Against Hepatitis C VirusNational Institute Of Allergy And Infectious Diseases2007–2011